April 16, 2014 Ajinomoto Pharmaceuticals Co., Ltd. Phase 2a Clinical Study Data of AJM300, an Oral 4 Integrin Antagonist, Will Be Presented in Digestive Disease Week 2014 - Ajinomoto - Document - PDFSEARCH.IO

First Page	Meta Content
	April 16, 2014 Ajinomoto Pharmaceuticals Co., Ltd. Phase 2a Clinical Study Data of AJM300, an Oral 4 Integrin Antagonist, Will Be Presented in Digestive Disease Week 2014 Add to Reading List Document Date: 2014-04-14 23:44:58 Open Document File Size: 163,99 KB Share Result on Facebook

April 16, 2014 Ajinomoto Pharmaceuticals Co., Ltd. Phase 2a Clinical Study Data of AJM300, an Oral 4 Integrin Antagonist, Will Be Presented in Digestive Disease Week 2014Add to Reading List